Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
39
XTNT Quote, Financials, Valuation and Earnings
Last price:
$0.58
Seasonality move
:
-6.33%
Day range:
$0.58 - $0.59
52-week range:
$0.34 - $0.95
Dividend yield:
0%
P/E ratio:
56.87x
P/S ratio:
0.63x
P/B ratio:
1.61x
Volume:
68.9K
Avg. volume:
175.7K
1-year change:
-1.84%
Market cap:
$81.2M
Revenue:
$117.3M
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.3M | $0.04 | 20.01% | -91.85% | $24.62 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.3% | 75.74% | $104.75 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.58 | $1.50 | $81.2M | 56.87x | $0.00 | 0% | 0.63x |
|
ABT
Abbott Laboratories
|
$112.21 | $133.39 | $195.1B | 30.19x | $0.63 | 2.14% | 4.43x |
|
ARAY
Accuray, Inc.
|
$0.54 | $2.53 | $60.7M | 149.00x | $0.00 | 0% | 0.14x |
|
ATEC
Alphatec Holdings, Inc.
|
$13.01 | $24.62 | $1.9B | -- | $0.00 | 0% | 2.65x |
|
BSX
Boston Scientific Corp.
|
$74.58 | $104.75 | $110.6B | 38.46x | $0.00 | 0% | 5.55x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.28 | $5.50 | $37.8M | -- | $0.00 | 0% | 4.41x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.714 | 35.76% | 1.08x |
|
ABT
Abbott Laboratories
|
21.33% | 0.141 | 6.97% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.394 | 177.87% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.39% | 1.400 | 27.26% | 1.21x |
|
BSX
Boston Scientific Corp.
|
33.07% | 0.200 | 8.46% | 0.94x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATEC
Alphatec Holdings, Inc.
|
$118.1M | -$9.4M | -25.96% | -1495.13% | -4.79% | $3.1M |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
Xtant Medical Holdings, Inc. vs. Competitors
-
Which has Higher Returns XTNT or ABT?
Abbott Laboratories has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of 15.71%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About XTNT or ABT?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 158.58%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 18.88%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Abbott Laboratories, analysts believe Xtant Medical Holdings, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 ABTAbbott Laboratories16 7 0 -
Is XTNT or ABT More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.041, which suggesting that the stock is 104.125% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock XTNT or ABT?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.14% to investors and pays a quarterly dividend of $0.63 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios XTNT or ABT?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. Xtant Medical Holdings, Inc.'s net income of $1.3M is lower than Abbott Laboratories's net income of $1.8B. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 56.87x while Abbott Laboratories's PE ratio is 30.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.63x versus 4.43x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.63x 56.87x $33.3M $1.3M ABTAbbott Laboratories4.43x 30.19x $11.5B $1.8B
-
Which has Higher Returns XTNT or ARAY?
Accuray, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -13.47%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About XTNT or ARAY?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 158.58%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 371.7%. Given that Accuray, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Accuray, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 ARAYAccuray, Inc.2 0 0 -
Is XTNT or ARAY More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.041, which suggesting that the stock is 104.125% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.151, suggesting its more volatile than the S&P 500 by 15.124%.
-
Which is a Better Dividend Stock XTNT or ARAY?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or ARAY?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 56.87x while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.63x versus 0.14x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.63x 56.87x $33.3M $1.3M ARAYAccuray, Inc.0.14x 149.00x $102.2M -$13.8M
-
Which has Higher Returns XTNT or ATEC?
Alphatec Holdings, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -14.54%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M ATECAlphatec Holdings, Inc.60.12% -$0.19 $626.3M -
What do Analysts Say About XTNT or ATEC?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 158.58%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 89.2%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Alphatec Holdings, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Alphatec Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is XTNT or ATEC More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.041, which suggesting that the stock is 104.125% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.34%.
-
Which is a Better Dividend Stock XTNT or ATEC?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or ATEC?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $196.5M. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 56.87x while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.63x versus 2.65x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.63x 56.87x $33.3M $1.3M ATECAlphatec Holdings, Inc.2.65x -- $196.5M -$28.6M
-
Which has Higher Returns XTNT or BSX?
Boston Scientific Corp. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of 12.68%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About XTNT or BSX?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 158.58%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.75 which suggests that it could grow by 40.45%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Boston Scientific Corp., analysts believe Xtant Medical Holdings, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 BSXBoston Scientific Corp.25 0 0 -
Is XTNT or BSX More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.041, which suggesting that the stock is 104.125% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.
-
Which is a Better Dividend Stock XTNT or BSX?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or BSX?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Xtant Medical Holdings, Inc.'s net income of $1.3M is lower than Boston Scientific Corp.'s net income of $670M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 56.87x while Boston Scientific Corp.'s PE ratio is 38.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.63x versus 5.55x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.63x 56.87x $33.3M $1.3M BSXBoston Scientific Corp.5.55x 38.46x $5.3B $670M
-
Which has Higher Returns XTNT or PSTV?
Plus Therapeutics, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -316.61%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About XTNT or PSTV?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 158.58%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1900%. Given that Plus Therapeutics, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is XTNT or PSTV More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.041, which suggesting that the stock is 104.125% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock XTNT or PSTV?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or PSTV?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 56.87x while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.63x versus 4.41x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.63x 56.87x $33.3M $1.3M PSTVPlus Therapeutics, Inc.4.41x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 23
RingCentral, Inc. [RNG] is down 12.48% over the past day.
Sell
9
FROG alert for Feb 23
JFrog Ltd. [FROG] is down 7.95% over the past day.
Buy
72
SNSE alert for Feb 23
Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.
